These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22082579)

  • 1. In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent.
    Yazdani SK; Vorpahl M; Nakano M; Su SH; Kolodgie FD; Virmani R
    EuroIntervention; 2011 Nov; 7(7):835-43. PubMed ID: 22082579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimus-eluting stents.
    Watanabe T; Fujita M; Awata M; Iida O; Okamoto S; Ishihara T; Uematsu M
    Cardiovasc Interv Ther; 2014 Jan; 29(1):4-10. PubMed ID: 23818255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.
    Pendyala LK; Matsumoto D; Shinke T; Iwasaki T; Sugimoto R; Hou D; Chen JP; Singh J; King SB; Chronos N; Li J
    JACC Cardiovasc Interv; 2012 Apr; 5(4):436-44. PubMed ID: 22516402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
    Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
    Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M
    EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
    Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
    JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
    van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
    JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
    Grube E; Schofer J; Hauptmann KE; Nickenig G; Curzen N; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2010 Apr; 3(4):431-8. PubMed ID: 20398872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
    Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
    EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.
    Smits PC; Hofma S; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; Vuillomenet A; Serra A; Nouche RT; den Heijer P; van der Ent M
    Lancet; 2013 Feb; 381(9867):651-60. PubMed ID: 23374650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents.
    Basalus MW; Tandjung K; van Westen T; Sen H; van der Jagt PK; Grijpma DW; van Apeldoorn AA; von Birgelen C
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):644-53. PubMed ID: 21805599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: the e-BioMatrix multicenter post marketing surveillance registry in India.
    Mehta AB; Chandra P; Dalal J; Shetty P; Desai D; Chocklingam K; Prajapati J; Kumar P; Magarkar V; Vasawada A; Goyal BK; Kumar V; Rao VS; Babu R; Parikh P; Kaul U; Patil A; Mhetre T; Rangnekar H
    Indian Heart J; 2013; 65(5):593-9. PubMed ID: 24206883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent Coating Integrity of Durable and Biodegradable Coated Drug Eluting Stents.
    Yazdani SK; Sheehy A; Pacetti S; Rittlemeyer B; Kolodgie FD; Virmani R
    J Interv Cardiol; 2016 Oct; 29(5):483-490. PubMed ID: 27282892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
    Hagiwara H; Hiraishi Y; Terao H; Hirai T; Sakaoka A; Sasaki M; Murota S; Inoue K; Kimura J
    EuroIntervention; 2012 Oct; 8(6):743-51. PubMed ID: 23086793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.